Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine
- PMID: 15310020
- PMCID: PMC6147811
- DOI: 10.5144/0256-4947.2004.55
Extended spectrum beta-lactamases in Eschericia coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine
References
-
- Yates RR. New Intervention strategies for reducing antibiotic resistance. Chest. 1999;115:24–27. - PubMed
-
- Luzzaro F, Perilli M, Amicosante G, Lombardi G, Belloni R, Zollo A, bianchi C, Toniolo A. Properties of multi-drug resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Int J Antimicrobial Agents. 2001;17(2):131–135. - PubMed
-
- Kaye KS, Fraimow HS, Abrutyn E. Pathogens resistant to antimicrobial agents. Epidemiology, molecular mechanisms and clinical management. Infect Dis Clin North Am. 2000;12(2):293–319. - PubMed
-
- Hobson RP, MacKenzie FM, Gould IM. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampion region of Scotland. J Hosp Infect. 1996;33:249–62. - PubMed
-
- Cormican M, Morris D, Corbett-Feeney G, Flynn J. Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection. Diag Microbiol Infect Dis. 1998;32:317–319. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical